Number To Know…1,000
Executive Summary
Vigilant Biosciences has initiated a US FDA clinical study, with plans to recruit up to 1,000 patients, of its OncAlert point-of-care oral cancer risk assessment test.
You may also be interested in...
EFSA's Lower Safe Intake Level For Selenium Stands Despite Supplement Industry’s Objections
The European Food Safety Authority has rejected a request from industry association Food Supplements Europe to apply its new lower intake limit for selenium to only selenomethionine and not other forms authorized for use in supplements.
Instead Of VC, Try Philanthropy: Inside Medical Research Charity LifeArc
In Vivo reporter Chloe Kent caught up with Life Arc CEO Melanie Lee to discuss the power of philanthropy in early-stage biopharma funding.
Execs On The Move: January 2023
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.